Cargando…
Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis
Although cell-free DNA (cfDNA) tests have emerged as a potential non-invasive alternative to bone marrow biopsies for monitoring clonal hematopoiesis in hematologic diseases, whether commercial cfDNA assays can be implemented for the detection and quantification of de novo clonal hematopoiesis in pl...
Autores principales: | Gutierrez-Rodrigues, Fernanda, Beerman, Isabel, Groarke, Emma M., Patel, Bhavisha A., Spitofsky, Nina, Dillon, Laura W., Raffo, Diego Quinones, Hourigan, Christopher S., Kajigaya, Sachiko, Ferrucci, Luigi, Young, Neal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335099/ https://www.ncbi.nlm.nih.gov/pubmed/34587721 http://dx.doi.org/10.3324/haematol.2021.279230 |
Ejemplares similares
-
Association of clonal hematopoiesis with chronic obstructive pulmonary disease
por: Miller, Peter G., et al.
Publicado: (2022) -
TET2-mutant clonal hematopoiesis and risk of gout
por: Agrawal, Mridul, et al.
Publicado: (2022) -
De novo hematopoiesis from the fetal lung
por: Yeung, Anthony K., et al.
Publicado: (2023) -
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
por: Stelmach, Patrick, et al.
Publicado: (2023) -
Aging drives Tet2(+/−) clonal hematopoiesis via IL-1 signaling
por: Caiado, Francisco, et al.
Publicado: (2023)